Cargando…

Conjunctivitis in patients with atopic dermatitis treated with dupilumab

Atopic dermatitis (AD) is a common, chronic, inflammatory skin disorder with high physical and emotional burden. Robust evidence suggests that interleukin (IL)-4 and IL-13 are key cytokines in the immunopathogenesis of AD. New emerging agents include dupilumab, a fully human monoclonal antibody dire...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferreira, Sandra, Torres, Tiago
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216785/ https://www.ncbi.nlm.nih.gov/pubmed/32426016 http://dx.doi.org/10.7573/dic.2020-2-3

Ejemplares similares

Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma
por: Bansal, Ashish, et al.
Publicado: (2021)

Transient Increase in Circulating Basophils and Eosinophils in Dupilumab-associated Conjunctivitis in Patients with Atopic Dermatitis
por: KATSUTA, Michie, et al.
Publicado: (2021)

Dupilumab for atopic dermatitis
Publicado: (2019)

Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion
por: Thyssen, J.P., et al.
Publicado: (2019)

Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
por: Gelato, Federica, et al.
Publicado: (2023)

Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
por: Dubini, Marco, et al.
Publicado: (2023)

Persistent Neutrophil Infiltration and Unique Ocular Surface Microbiome Typify Dupilumab–Associated Conjunctivitis in Patients with Atopic Dermatitis
por: Patra, VijayKumar, et al.
Publicado: (2023)

Atopic Dermatitis with Multiple Comorbidities Treated with Dupilumab. A Case Report and Review of the Literature Regarding the Safety of Dupilumab
por: Mitroi, George G., et al.
Publicado: (2022)

Practical Management of Patients with Atopic Dermatitis on Dupilumab
por: Papp, Kim A., et al.
Publicado: (2021)

Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective
por: de Bruin-Weller, Marjolein, et al.
Publicado: (2021)

The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis
por: Kamal, Mohamed A., et al.
Publicado: (2021)

Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
por: Shan, Jinpeng, et al.
Publicado: (2022)

Remission of alopecia universalis in a patient with atopic dermatitis treated with dupilumab
por: Smogorzewski, Jan, et al.
Publicado: (2019)

Immune Thrombocytopenic Purpura in a Patient with Atopic Dermatitis Treated with Dupilumab
por: FREY, Surina, et al.
Publicado: (2021)

Purpuric Drug Eruption in a Patient with Atopic Dermatitis Treated with Dupilumab
por: WANG, Mingxia, et al.
Publicado: (2022)

New Onset of Alcohol Flushing in an Atopic Dermatitis Patient Treated with Dupilumab
por: Choi, Hoon, et al.
Publicado: (2023)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
por: Zubek, Amanda E., et al.
Publicado: (2020)

Alopecia areata after dupilumab for atopic dermatitis
por: Mitchell, Krystal, et al.
Publicado: (2018)

Improvement of atopic dermatitis and alopecia universalis with dupilumab
por: Alotaibi, Lama, et al.
Publicado: (2021)

Patient Reported Outcome Measure in Atopic Dermatitis Patients Treated with Dupilumab: 52-Weeks Results
por: Marron, Servando E., et al.
Publicado: (2021)

Facial Redness in Atopic Dermatitis Patients Treated With Dupilumab: A Case Series
por: Seok, Seung Hui, et al.
Publicado: (2020)

Alcohol-induced facial flushing in a patient with atopic dermatitis treated with dupilumab
por: Igelman, Sean J., et al.
Publicado: (2020)

Transitory Dissemination of Molluscum Contagiosum in a Patient Treated with Dupilumab for Atopic Dermatitis
por: FERRUCCI, Silvia, et al.
Publicado: (2020)

The evaluation of dupilumab treatment response in atopic dermatitis patients
por: Askin, Ozge, et al.
Publicado: (2020)

Work ability and quality of working life in atopic dermatitis patients treated with dupilumab
por: Bosma, Angela L., et al.
Publicado: (2021)

Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis
por: WOLLENBERG, Andreas, et al.
Publicado: (2022)

Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis
por: Eshtiaghi, Panteha, et al.
Publicado: (2018)

Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study
por: Johansson, Emma Kristin, et al.
Publicado: (2020)

COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
por: Ungar, Benjamin, et al.
Publicado: (2022)

Ocular Adverse Effects in Atopic Dermatitis Patients Treated With Dupilumab: A Bibliometric Analysis
por: Jia, Qian-Nan, et al.
Publicado: (2022)

Pustular Psoriasis in a Patient Treated with Dupilumab for Atopic Dermatitis: A Case Report
por: Liu, Li, et al.
Publicado: (2023)

Recalcitrant erythrodermic ichthyosis with atopic dermatitis successfully treated with Dupilumab in combination with Guselkumab
por: Steinhoff, M., et al.
Publicado: (2021)

Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature
por: Lobo, Yolanka, et al.
Publicado: (2021)

Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
por: Esposito, Maria, et al.
Publicado: (2022)

Dupilumab: Direct Cost and Clinical Evaluation in Patients with Atopic Dermatitis
por: Ferrari, Marco, et al.
Publicado: (2023)

The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis
por: Spekhorst, Lotte S., et al.
Publicado: (2023)

Effectiveness of dupilumab for chronic prurigo in elderly patients with atopic dermatitis()
por: Mitsuyama, Shinji, et al.
Publicado: (2023)

Treatment of Severe Atopic Dermatitis with Dupilumab in Patients with Advanced Cancer
por: Tanczosova, Milena, et al.
Publicado: (2023)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
por: Cho, Sung Kyung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nt6ab1emqji7is5skdj5eiq84n